OmniAb Inc.

OmniAb, Inc. is a biotechnology company that licenses discovery research technology to pharmaceutical and biotech companies and academic institutions in the United States, Europe, Japan, China, and Canada. Its platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development. The company offers animal-based technologies such as OmniRat, OmniChicken, and OmniMouse, which are genetically modified to generate antibodies with human sequences; OmniFlic and OmniClic for bispecific antibody discovery; OmniTaur for challenging targets; OmnidAb for single-domain antibodies; and OmniDeep, a suite of in silico AI and machine learning tools. OmniAb also has an agreement with mAbsolve Ltd. for its Fc-silencing platform technology. Founded in 2012, OmniAb is headquartered in Emeryville, California.